DJIA 17,856.78 -278.94 -1.54%
NASDAQ 4,927.37 -55.44 -1.11%
S&P 500 2,071.26 -29.78 -1.42%
market minute promo

40.67 -0.25 (-0.61%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NBIX $40.67 -0.61%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $40.67
Previous Close $40.92
Daily Range $39.93 - $41.24
52-Week Range $12.17 - $42.38
Market Cap $3.1B
P/E Ratio -50.52
Dividend (Yield) $0.00 (0.0%)
Volume 1,167,688
Average Daily Volume 1,149,383
Current FY EPS -$1.04

Sector

Healthcare

Industry

Drug Makers

Neurocrine Biosciences, Inc. (NBIX) Description

Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis. Website: http://www.neurocrine.com/

News & Commentary Rss Feed

NBIX's Top Competitors

NBIX $40.67 (-0.61%)
Current stock: NBIX
CELG $118.03 (-2.22%)
Current stock: CELG
AMGN $154.88 (-2.96%)
Current stock: AMGN
BIIB $417.63 (-1.87%)
Current stock: BIIB